Parisa D. — MSCA Alumnus · Bionics
Parisa D.
“I am originally from Iran, studied in Italy and later moved to Czechia for research. My current question is whether to pursue MSCA, another fellowship or a research-company path around my bionics work.”
What this situation means
This profile represents a common international research-career situation: a researcher is already building academic or R&D experience while also trying to choose between Marie Skłodowska-Curie Actions, other European grants, industry, commercialisation, entrepreneurship and longer-term professional stability. The most useful route depends on timing, proposal maturity, publications, host options and the researcher’s broader objectives.
Relevant support routes
Cademix can combine proposal development and review, alternative funding, industry transition, commercialisation, entrepreneurship, startup development, research-centre development and mentoring according to the researcher’s stage. The purpose is to create several credible next steps around the same research profile rather than depend on one application outcome.
Questions researchers often ask
What is the purpose of this page?
This page explains a specific part of MSCA Career Acceleration and connects it to practical research, funding and career decisions.
Who is this information most relevant to?
It is relevant to future applicants, researchers with an unfunded proposal, current Marie Skłodowska-Curie fellows and alumni, depending on the topic.
Where can current MSCA call rules be checked?
Current rules should be verified through the European Commission, Funding & Tenders Portal and European Research Executive Agency resources before any time-sensitive decision.
What usually weakens an otherwise strong MSCA proposal?
Common weaknesses include unclear research objectives, weak evidence for claims, poor researcher-host complementarity, generic training, unrealistic implementation, and impact statements that are not connected to measurable activities or users.
When is external proposal review most useful?
It is most useful after a complete first structure exists but early enough to change scientific logic, work packages, training, impact and implementation rather than only correcting language near the deadline.
Should every evaluator comment be followed literally?
No. Feedback should be interpreted in context. The goal is to identify the underlying weakness and strengthen the proposal while preserving scientific coherence and compliance with the current call.
How many funding routes should a researcher keep active?
There is no fixed number, but relying on one call creates unnecessary risk. A practical portfolio can include MSCA, national or regional grants, institutional funding, industry-linked projects and other European programmes that fit the same research direction.